Clinical Trial

Phase II Study of Resistant Potato Starch Plus Deferasirox to Improve Outcomes in Patients Undergoing Allogeneic Stem Cell Transplantation

Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
The study will evaluate the safety and early efficacy of administering the combination of a commercially available potato-based resistant starch along with iron chelation therapy to subjects undergoing alloHCT.
Protocol Amendment History 6 amendments
This ClinicalTrials.gov record has been amended 6 times since 2025-01-14; most recent amendment 2026-07-19.
Status change: Not Yet Recruiting → Recruiting 2025-09-08
Trial Details
NCT Number NCT06784336
Lead Sponsor University of Michigan Rogel Cancer Center
Conditions Allogeneic Stem Cell Transplant
Enrollment 50 participants
Start Date 2025-10-15
Primary Completion 2028-10 (estimated)
Study Completion 2029-10 (estimated)
Updated on ClinicalTrials.gov 2026-07-21